(Q44544970)

English

An open-label comparison of nabilone and gabapentin as adjuvant therapy or monotherapy in the management of neuropathic pain in patients with peripheral neuropathy

scientific article published on 18 November 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

An open-label comparison of nabilone and gabapentin as adjuvant therapy or monotherapy in the management of neuropathic pain in patients with peripheral neuropathy (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

neuropathic pain

0 references

0 references

pain management

0 references

author name string

Jennifer A Bestard

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Cory C Toth

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

publication date

18 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

353-368

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Peripheral neuropathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00427.X

21 January 2018

The Nottingham Health Profile as a measure of quality of life in zoster patients: convergent and discriminant validity.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00427.X

21 January 2018

The burden of neuropathic pain: results from a cross-sectional survey.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00427.X

21 January 2018

Peripheral neuropathic pain--a multidimensional burden for patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00427.X

21 January 2018

Morphine, gabapentin, or their combination for neuropathic pain.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00427.X

21 January 2018

Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00427.X

21 January 2018

Plant, synthetic, and endogenous cannabinoids in medicine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00427.X

21 January 2018

Endocannabinoid mechanisms of pain modulation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00427.X

21 January 2018

CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00427.X

21 January 2018

The synthetic cannabinoid WIN55,212-2 attenuates hyperalgesia and allodynia in a rat model of neuropathic pain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00427.X

21 January 2018

The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00427.X

21 January 2018

Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00427.X

21 January 2018

Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00427.X

21 January 2018

Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00427.X

21 January 2018

Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00427.X

21 January 2018

Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00427.X

21 January 2018

Low dose treatment with the synthetic cannabinoid Nabilone significantly reduces spasticity-related pain : a double-blind placebo-controlled cross-over trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00427.X

21 January 2018

Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00427.X

21 January 2018

Effects of nabilone, a synthetic cannabinoid, on postoperative pain.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00427.X

21 January 2018

Experience with the synthetic cannabinoid nabilone in chronic noncancer pain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00427.X

21 January 2018

Nabilone for the treatment of pain in fibromyalgia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00427.X

21 January 2018

The effects of nabilone on sleep in fibromyalgia: results of a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00427.X

21 January 2018

A prospective identification of neuropathic pain in specific chronic polyneuropathy syndromes and response to pharmacological therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00427.X

21 January 2018

Simple screening tests for peripheral neuropathy in the diabetes clinic.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00427.X

21 January 2018

Validation of a modified version of the brief pain inventory for painful diabetic peripheral neuropathy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00427.X

21 January 2018

Variations in population health status: results from a United Kingdom national questionnaire survey

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00427.X

21 January 2018

The hospital anxiety and depression scale

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00427.X

21 January 2018

A comparison of the SF-36 and Nottingham Health Profile in patients with chronic neuropathic pain.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00427.X

21 January 2018

Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00427.X

21 January 2018

Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00427.X

21 January 2018

Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00427.X

21 January 2018

Sativex successfully treats neuropathic pain characterised by allodynia: a randomised, double-blind, placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00427.X

21 January 2018

Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00427.X

21 January 2018

Gabapentin as a potential treatment for anxiety disorders.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00427.X

21 January 2018

Preoperative gabapentin decreases anxiety and improves early functional recovery from knee surgery

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00427.X

21 January 2018

EFNS guidelines on pharmacological treatment of neuropathic pain.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00427.X

21 January 2018

Identifiers

10.1111/J.1533-2500.2010.00427.X

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

release_siccjdz2u5efjmwymy3djkaoty

1 reference

https://api.fatcat.wiki/v0/release/siccjdz2u5efjmwymy3djkaoty

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44544970&oldid=2027256606"